(IN BRIEF) Novadip, a Belgian biotech company, has secured €18 million in venture debt financing from the European Investment Bank (EIB) with support from the European Union’s InvestEU initiative. The funds will be utilized for clinical trials of NVD-003, an … Read the full press release →
Posted in Banks, Business, Environment, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Technology
Tagged Bone Repair Treatment Novadip, clinical trials, Denis Dufrane, EIB, innovative, Kris Peeters, Novadip, partnership, sustainability